Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TG Therapeutics
Biotech
Precision deals out CAR-T autoimmune rights to TG for $10M
Precision's full pivot to gene editing is nearly complete after selling azer cel's ex-oncology development rights to TG Therapeutics.
Max Bayer
Jan 9, 2024 10:14am
TG's pivot to MS faces setback as FDA pushes approval
May 31, 2022 9:40am
UPDATE: TG disbands cancer program after pulling U2 request
Apr 18, 2022 11:11am
Biotech leaders call on industry to cut ties with Russia
Feb 24, 2022 4:00pm
FDA expands oversight over TG's stalled U2 cancer combo therapy
Jan 28, 2022 8:15am
FDA orders advisory meeting for TG's U2 leukemia combo
Nov 30, 2021 9:35am
